J. Hagan Capital’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,385
Closed -$240K 83
2025
Q2
$240K Buy
+14,385
New +$280K 0.16% 68

Other funds holding BTAL

J. Hagan Capital's BTAL Position: Q3 2025 in Review

J. Hagan Capital sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2025, closing a stake of 14,385 shares — an estimated $240K sold.

J. Hagan Capital first reported a position in BTAL in Q2 2025 and held it in 1 quarter. The position peaked at $240K in Q2 2025. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2025.

  • J. Hagan Capital reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2025 after selling out during the quarter.
  • J. Hagan Capital sold 14,385 AGF US Market Neutral Anti-Beta Fund shares in Q3 2025, an estimated $240K.
  • J. Hagan Capital first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2025 and held it in 1 quarter.
  • J. Hagan Capital's AGF US Market Neutral Anti-Beta Fund position peaked at $240K in Q2 2025.
  • 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2025.

Based on J. Hagan Capital's 13F filing for Q3 2025, filed 13 Nov 2025.